Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000564564 | SCV000673353 | benign | Hereditary cancer-predisposing syndrome | 2023-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001529212 | SCV000834540 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529212 | SCV001764533 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genetic Services Laboratory, |
RCV001821687 | SCV002067544 | uncertain significance | not specified | 2018-10-25 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001821687 | SCV004243528 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248291 | SCV005896455 | likely benign | Hereditary leiomyomatosis and renal cell cancer | 2024-10-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Diagnostic Laboratory, |
RCV001529212 | SCV001742293 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529212 | SCV001807472 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529212 | SCV001953236 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000705539 | SCV002085856 | uncertain significance | Fumarase deficiency | 2020-08-12 | no assertion criteria provided | clinical testing |